BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38280007)

  • 41. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a concise review and update.
    Hong JY; Ko YH; Kim SJ; Kim WS
    Curr Opin Oncol; 2015 Sep; 27(5):392-8. PubMed ID: 26258272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.
    Castillo JJ; Beltran BE; Miranda RN; Paydas S; Winer ES; Butera JN
    Oncologist; 2011; 16(1):87-96. PubMed ID: 21212426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk-stratification, and management.
    Malpica L; Marques-Piubelli ML; Beltran BE; Chavez JC; Miranda RN; Castillo JJ
    Am J Hematol; 2022 Jul; 97(7):951-965. PubMed ID: 35472248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequent downregulation of BTB and CNC homology 2 expression in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Noujima-Harada M; Takata K; Miyata-Takata T; Sakurai H; Igarashi K; Ito E; Nagakita K; Taniguchi K; Ohnishi N; Omote S; Tabata T; Sato Y; Yoshino T
    Cancer Sci; 2017 May; 108(5):1071-1079. PubMed ID: 28256087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
    Alame M; Pirel M; Costes-Martineau V; Bauchet L; Fabbro M; Tourneret A; De Oliveira L; Durand L; Roger P; Gonzalez S; Cacheux V; Rigau V; Szablewski V
    Virchows Arch; 2020 Jun; 476(6):891-902. PubMed ID: 31811434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments.
    Nakhoul H; Lin Z; Wang X; Roberts C; Dong Y; Flemington E
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31292228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Beltran BE; Quiñones P; Morales D; Malaga JM; Chavez JC; Sotomayor EM; Castillo JJ
    Hematol Oncol; 2018 Feb; 36(1):93-97. PubMed ID: 28639256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
    Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
    Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management.
    Beltran BE; Castro D; Paredes S; Miranda RN; Castillo JJ
    Am J Hematol; 2020 Apr; 95(4):435-445. PubMed ID: 32072672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of EBV-encoded small RNA targeted PCR to classify EBV positive diffuse large B-cell lymphoma (DLBCL) of the elderly.
    Lee J; Park M; Lee MH; Woo HJ; Kim HW; Yang JY; Eom YB; Kim SH; Yoo C; Kim JB
    Int J Clin Exp Pathol; 2015; 8(7):7859-68. PubMed ID: 26339350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Role of EBV in the Pathogenesis of Diffuse Large B Cell Lymphoma.
    Healy JA; Dave SS
    Curr Top Microbiol Immunol; 2015; 390(Pt 1):315-37. PubMed ID: 26424652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epstein-Barr virus-positive iris diffuse large B-cell lymphoma detected by metagenomic next-generation sequencing.
    Wang XN; Hong J; Xu YG; Zhang P; Li YY; Dou HL; Li HP
    BMC Ophthalmol; 2024 Mar; 24(1):99. PubMed ID: 38438866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC-subtype diffuse large B-cell lymphoma.
    Vockerodt M; Vrzalikova K; Ibrahim M; Nagy E; Margielewska S; Hollows R; Lupino L; Tooze R; Care M; Simmons W; Schrader A; Perry T; Abdullah M; Foster S; Reynolds G; Dowell A; Rudzki Z; Krappmann D; Kube D; Woodman C; Wei W; Taylor G; Murray PG
    J Pathol; 2019 Jun; 248(2):142-154. PubMed ID: 30666658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prevalence and clinico-pathological characteristics in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma in a high complexity hospital in Cali, Columbia].
    Amaya D; Moreno JC; Calvache N; Castro A; Pérez B; Silva N
    Rev Esp Patol; 2019; 52(3):139-146. PubMed ID: 31213254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer.
    Ikeda T; Gion Y; Sakamoto M; Tachibana T; Nishikori A; Nishimura MF; Yoshino T; Sato Y
    Mod Pathol; 2020 Dec; 33(12):2437-2448. PubMed ID: 32561847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
    Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
    PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advances in the Pathogenesis of EBV-Associated Diffuse Large B Cell Lymphoma.
    Chabay P
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
    Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Onset of pulmonary Epstein-Barr virus-positive diffuse large B-cell lymphoma in a patient with silicosis.
    Ogata R; Soda H; Tanaka Y; Senju H; Shimada M; Yamashita K; Nakashima S; Umemura A; Yoshida M; Hara T; Jinnai S; Iwasaki K; Fukuda Y; Yamaguchi H; Mukae H
    Thorac Cancer; 2022 Jan; 13(1):133-136. PubMed ID: 34821472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.